Gibson Energy Inc. (GBNXF)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,019	2,774	2,464	2,513	2,596	2,363
Market Cap Growth	3.91%	12.58%	-1.96%	-3.19%	9.88%	-20.78%
Enterprise Value	4,995	4,528	4,478	3,660	3,857	3,465
Last Close Price	18.37	16.42	13.67	14.41	13.80	11.66
PE Ratio	25.89	26.23	15.19	15.24	22.65	24.82
PS Ratio	0.38	0.34	0.30	0.31	0.46	0.61
PB Ratio	4.82	4.11	3.57	5.94	5.10	4.43
P/TBV Ratio	11.59	8.86	8.43	18.70	13.15	10.61
P/FCF Ratio	8.74	9.43	7.32	7.43	33.14	12.32
P/OCF Ratio	5.94	6.67	5.66	5.69	15.15	6.55
EV/Sales Ratio	0.64	0.55	0.54	0.45	0.68	0.89
EV/EBITDA Ratio	12.45	13.13	11.96	11.02	12.80	11.66
EV/EBIT Ratio	18.72	19.44	15.58	14.82	20.64	17.87
EV/FCF Ratio	14.46	15.39	13.31	10.82	49.24	18.06
Debt / Equity Ratio	3.23	2.72	3.04	3.00	2.71	2.28
Debt / EBITDA Ratio	5.23	5.07	5.31	3.59	4.25	3.73
Debt / FCF Ratio	5.86	6.25	6.24	3.75	17.58	6.35
Asset Turnover	2.21	2.38	2.71	3.33	2.22	1.63
Inventory Turnover	49.05	48.62	41.75	41.50	33.06	30.85
Quick Ratio	0.58	0.54	0.82	0.80	0.93	0.74
Current Ratio	0.71	0.73	1.12	1.20	1.26	1.10
Return on Equity (ROE)	17.54%	16.15%	28.84%	36.68%	21.92%	16.84%
Return on Assets (ROA)	4.40%	4.22%	5.83%	6.30%	4.55%	5.11%
Return on Capital (ROIC)	5.82%	5.73%	7.94%	8.93%	6.40%	7.07%
Return on Capital Employed (ROCE)	9.40%	9.30%	9.50%	13.30%	9.00%	9.70%
Earnings Yield	3.86%	3.81%	6.58%	6.56%	4.42%	4.03%
FCF Yield	11.44%	10.60%	13.66%	13.46%	3.02%	8.12%
Dividend Yield	6.63%	6.94%	8.64%	7.59%	8.02%	9.15%
Payout Ratio	170.20%	172.86%	105.86%	95.80%	140.18%	162.60%
Buyback Yield / Dilution	-1.49%	-8.09%	-1.93%	0.21%	-0.26%	-0.74%
Total Shareholder Return	5.14%	-1.15%	6.71%	7.80%	7.75%	8.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.